• NeuroSTAT Project Receives FDA Fast Track Designation americanpharmaceuticalreview
    July 30, 2019
    NeuroVive announced the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the US Food and Drug Administration ...
  • NeuroVive to continue NeuroSTAT clinical development pharmaasia
    June 06, 2017
PharmaSources Customer Service